News
Oncologist who served as FDA’s chief medical officer, top vaccine official departs agency
A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the agency.HHS confirmed the departure of Vinay K. Prasad, MD, MPH, providing the following statement to Healio: “Dr.
Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic of the agency’s COVID-19 policies, has departed after being on the job ...
InvestorsHub on MSN2d
Novo Nordisk appoints Mike Doustdar as new CEO; Chief Scientific Officer to retire
Novo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...
17hon MSN
Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job
Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.
Founder Jeremy Brown, Ph.D. to continue as Chief Technical Officer, driving scientific vision HALIFAX, NS, July 31, 2025 /CNW/ — Sound Blade Medical, Inc., a leader in handheld histotripsy ...
Illinois Gov. JB Pritzker and former U.S. Commerce Secretary Penny Pritzker are at the center of an effort to drive more ...
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
MyChesCo on MSN1d
Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback